Lindbrook Capital’s PMV Pharmaceuticals PMVP Stock Holding History

Lindbrook Capital’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-51	Closed	-$444	–	2882
2022 Q4	$444	Sell	51 -57	-53%	-$608	﹤0.01%	2616
2022 Q3	$1K	Sell	108 -17	-14%	-$246	﹤0.01%	2456
2022 Q2	$2K	Sell	125 -139	-53%	-$2.02K	﹤0.01%	2027
2022 Q1	$5K	Buy	+264	New	+$4.66K	﹤0.01%	1602

Other funds holding PMVP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lindbrook Capital's PMVP Position: Q1 2023 in Review

Lindbrook Capital sold out of PMV Pharmaceuticals (PMVP) in Q1 2023, closing a stake of 51 shares — an estimated $444 sold.

Lindbrook Capital first reported a position in PMVP in Q1 2022 and held it in 4 quarters. The position peaked at $5K in Q1 2022. 111 funds tracked by Wall St. Rank hold PMVP as of Q1 2023.

Lindbrook Capital reported no remaining PMV Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Lindbrook Capital sold 51 PMV Pharmaceuticals shares in Q1 2023, an estimated $444.
Lindbrook Capital first reported a position in PMV Pharmaceuticals in Q1 2022 and held it in 4 quarters.
Lindbrook Capital's PMV Pharmaceuticals position peaked at $5K in Q1 2022.
111 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2023.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.